HeartBeam Inc., a NASDAQ-traded medical technology company, has received the Innovation Award in Remote Cardiac Diagnostics for their FDA-cleared 3D ECG technology. This recognition showcases their dedication to remote cardiac care and highlights their advancements in clinical-grade arrhythmia diagnostics in non-clinical settings.
